The Life Sciences Law Review - 11th Edition

The Life Sciences Law Review - 11th Edition

Pages: 444

ISBN: 978-1-80449-153-9

  • $438.00

The Life Sciences Law Review is an overview of the legal and regulatory frameworks governing pharmaceutical, biotechnology and medical device companies in key jurisdictions worldwide. It covers the major rules and restrictions throughout the life cycle of regulated products, from discovery to clinical trials, the marketing authorisation process and post-approval controls. It also examines the most consequential recent trends and developments in the sector.

In this book: 


  • Editor’s Preface
    Peter Bogaert
    Covington & Burling LLP
  • International Harmonisation
    Richard Kingham
    Covington & Burling LLP


  • Argentina
  • Australia
  • Belgium
  • Brazil
  • Canada
  • China
  • European Union
  • Finland
  • France
  • Greece
  • Japan
  • Malta
  • Mexico
  • Netherlands
  • Peru
  • Portugal
  • Singapore
  • Slovenia
  • South Africa
  • Switzerland
  • United Arab Emirates
  • United Kingdom
  • United States
  • Venezuela

Peter Bogaert, Covington & Burling LLP

Peter Bogaert is a partner in the Brussels Covington & Burling LLP office, where he heads the life sciences practice. He has detailed regulatory expertise under EU and national laws, handles legislative and other policy assignments, and provides strategic advice. He also represents life sciences companies before the EU courts in Luxembourg and in local litigation in Belgium. Peter Bogaert's practice covers pharmaceuticals, biotechnology, medical devices, special foods and feed, cosmetics and other consumer products, and he represents numerous innovative life sciences companies, including start-ups, as well as several industry associations. He holds law degrees from the universities of Leuven and Oxford.

We Also Recommend